These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Preconception vaccination with a glycoprotein B (gB) DNA vaccine protects against cytomegalovirus (CMV) transmission in the guinea pig model of congenital CMV infection. Schleiss MR; Bourne N; Bernstein DI J Infect Dis; 2003 Dec; 188(12):1868-74. PubMed ID: 14673766 [TBL] [Abstract][Full Text] [Related]
9. Progress toward developing a cytomegalovirus vaccine. Marshall GS; Plotkin SA Infect Dis Clin North Am; 1990 Jun; 4(2):283-98. PubMed ID: 2161034 [TBL] [Abstract][Full Text] [Related]
10. Immunoprophylaxis of experimental cytomegalovirus infection. Minamishima Y Ann Microbiol (Paris); 1977 Oct; 128(3):399-407. PubMed ID: 203216 [TBL] [Abstract][Full Text] [Related]
11. Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine. Schleiss MR; Stroup G; Pogorzelski K; McGregor A Vaccine; 2006 Sep; 24(37-39):6175-86. PubMed ID: 16879902 [TBL] [Abstract][Full Text] [Related]
12. The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease. Adler SP; Nigro G Herpes; 2008 Nov; 15(2):24-7. PubMed ID: 19856544 [TBL] [Abstract][Full Text] [Related]
13. Comparison of vaccine strategies against congenital CMV infection in the guinea pig model. Schleiss MR J Clin Virol; 2008 Mar; 41(3):224-30. PubMed ID: 18060834 [TBL] [Abstract][Full Text] [Related]
14. [CMV infections]. Pawłowska M; Halota W Przegl Epidemiol; 2004; 58 Suppl 1():17-21. PubMed ID: 15807153 [TBL] [Abstract][Full Text] [Related]
15. Findings and conclusions from CMV hyperimmune globulin treatment trials. Adler SP; Nigro G J Clin Virol; 2009 Dec; 46 Suppl 4():S54-7. PubMed ID: 19781985 [TBL] [Abstract][Full Text] [Related]
16. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates. Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413 [TBL] [Abstract][Full Text] [Related]
17. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?]. Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432 [TBL] [Abstract][Full Text] [Related]
18. Prevention of cytomegalovirus infection after organ transplantation with passive immunization. An analysis of 6 randomized clinical trials. Metselaar H; Weimar W Beitr Infusionsther; 1992; 30():198-202. PubMed ID: 1284706 [TBL] [Abstract][Full Text] [Related]
19. [Congenital cytomegalic disease. Current possibilities and prospects of prevention]. Nardiello S; Galanti B Clin Ter; 1990 Sep; 134(5):281-7. PubMed ID: 2178077 [TBL] [Abstract][Full Text] [Related]
20. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. Bernstein DI; Schleiss MR; Berencsi K; Gonczol E; Dickey M; Khoury P; Cadoz M; Meric C; Zahradnik J; Duliege AM; Plotkin S J Infect Dis; 2002 Mar; 185(5):686-90. PubMed ID: 11865427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]